|
|
|
|
New Johns Hopkins Study Betters The Odds Of Success In Predicting The Return Of Prostate Cancer
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The...
|
|
|
Predicting the Return of Prostate Cancer: New Johns Hopkins Study Betters the Odds of Success
BALTIMORE, July 1 (AScribe Newswire) -- Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet...
|
|
|
Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care N
(Washington, D.C.) A bipartisan group of members from the U.S.House of Representatives introduced a bill late yesterday aimed at improving oncology care in the United States by refocusing efforts towards patient-centered cancer care...
|
|
|
Widely Used Cancer Drug Causes Potentially Deadly Holes in GI Tract
Key concepts: Cancer, Avastin and Cancer treatment to a friend Printable Version FREE Email Newsletter Articles Related to This Article: The mineral selenium proves itself as powerful anti-cancer medicine Cancer is...
|
|
|
Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The...
|
|
|
Prostate Cancer Patients Disease Free After 5 years Likely to be Disease Free After 10 Years
Health Conditions : Cancer : Prostate Cancer Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the...
|
|
|
Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience
aDivision of Radiation Oncology, bDepartment of Blood and Marrow Transplantation, cAcademic Programs, dDepartment of Gastrointestinal Medical Oncology, eDepartment of Pathology, fDepartment of Pediatrics, gDepartment of...
|
|
|
Cost-Effectiveness of Cancer Drugs Is Questioned
July 1, 2009 -- The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S.that needs to be addressed by the oncology community,...
|
|
|
Predicting the Return of Prostate Cancer: New Johns Hopkins Study Betters the Odds of Success- 7/1/09
PREDICTING THE RETURN OF PROSTATE CANCER: NEW JOHNS HOPKINS STUDY BETTERS THE ODDS OF SUCCESS Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a...
|
|
|
Predicting The Return Of Prostate Cancer: New Study Betters The Odds Of Success
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The...
|
|
|
June 2009 Briefing - Oncology
Here are what the editors at HealthDay consider to be the most important developments in Oncology for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
|
|
|
Combating Cancer
Cancer is not a single disease.It is many diseases that target various parts of the body, but all cancers are characterized by uncontrolled cellular growth. Ordinarily the body carefully controls cell growth, but when these...
|
|
|
Predicting the Return of Prostate Cancer: New Study Betters the Odds of Success
Newswise Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease...
|
|
|
New prostate cancer metastasis prediction method
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The...
|
|
|
June 2009 Briefing - Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
|
|
|
[Breast Cancer] Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutatio
From the Family Cancer Clinic, Departments of Medical Oncology, Oncological Surgery, and Clinical Genetics Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.* To whom correspondence should be addressed...
|
|
|
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Can
Journal of the National Cancer Institute Advance Access originally published online on June 17, 2009 2009 101(13):946-958; doi:10.1093/jnci/djp148 This Article Full Text Supplementary Data All Versions of this Article: 101/13/946 most...
|
|
|
Study Says High-Cost Cancer Drugs Have Little Benefit, Strain Health System
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Cancer / Oncology News Main Category: Cancer / Oncology Also Included In: Public Health email to a friend printer friendly view / write...
|
|
|
Cancer Therapies: How Much Is Life Worth? The $440 Billion Question
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S.that needs to be addressed by the oncology community, according to a...
|
|
|
Want to get screened for ovarian cancer? Find out why early detection remains elusive
Topics Medical Specialization Medical Services X Massachusetts Heartburn Women's Health Breast Cancer Diseases Medicines Yale University Boston Oncology Cancer Ovarian Cancer Symptoms Preventative Medicine E-mail...
|
|
|
Medical Professionals Issue Cost-Benefit Analysis Of Cancer Therapies
Two experts from the have released a new report which questions the use of expensive treatments for cancer patients that only extend their lifespan for a short time.In comments published in the , Tito Fojo, of the Medical ...
|
|
|
How much is life worth? The $440 billion question
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S.that needs to be addressed by the oncology community, according to a...
|
|
|
Functional RET G691S polymorphism in cutaneous malignant melanoma
1Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA 2Department of Anatomical Pathology, Sydney Cancer Center, Royal Prince Alfred Hospital, Camperdown,...
|
|
|
Medical News: Livestrong(R) Global Cancer Campaign Announces Groundbreaking New European Commitments To Cancer
Cancer / Oncology News Main Category: Cancer / Oncology email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: Today the...
|
|
|
Livestrong(R) Global Cancer Campaign Announces Groundbreaking New European Commitments To Cancer Control
Livestrong(R) Global Campaign Announces Groundbreaking New European Commitments To Control Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details of 26,000 UK specialists medical software Ask a Doctor and...
|
